Related Experiment Video
Updated: Jul 9, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
The outcome of heart failure in women: a study from a tertiary heart function clinic
Abeer Bakhsh1, Alaa AlSayed1, Mohammed AlTamimi1
1Advance Heart Failure, Prince Sultan Cardiac Centre Riyadh, Saudi Arabia.
Insights
Women with heart failure (HF) often present with reduced ejection fraction and dilated cardiomyopathy, facing high rates of obesity and chronic disease. Advanced HF therapies are underutilized in this population, necessitating improved access to specialized care.
Area of Science:
- Cardiology
- Women's Health
- Cardiovascular Disease
Background:
- Women experience unique cardiovascular disease risk factors and mortality rates.
- Heart failure (HF) prevalence in women is influenced by factors like age, pregnancy, and menopause.
- Further understanding of HF in women regarding etiology, management, and outcomes is crucial.
Purpose of the Study:
- To analyze the characteristics, causes, and outcomes of heart failure in women.
- To evaluate the prevalence of comorbidities and adverse pregnancy events in women with HF.
- To assess the utilization of advanced HF therapies and referral patterns in women.
Main Methods:
- Retrospective study of 561 women diagnosed with HF at a tertiary cardiac center's heart function clinic.
- Analysis of patient demographics, HF diagnosis, comorbidities (diabetes, hypertension, obesity), and pregnancy history.
- Review of treatment patterns, left ventricular recovery, and patient outcomes including chronic HF, heart transplant, and mortality.
Main Results:
- The majority of women (84%) presented with HF with reduced ejection fraction (HFrEF), most commonly due to dilated cardiomyopathy (54.2%).
- High prevalence of comorbidities including diabetes (48.5%), hypertension (47.6%), and obesity (59% with BMI ≥ 30).
- Significant rates of adverse pregnancy events (miscarriages 38.6%) and a substantial proportion of women living with chronic HF (42.8%), with low heart transplant rates (3.75%).
Conclusions:
- Women are underrepresented in specialized heart function clinics, indicating low referral rates.
- Obesity is highly prevalent, and most women experience chronic HF, yet advanced therapy consideration remains low.
- There is a critical need to improve access to specialized care and advanced HF therapies for women.
Background:
Women have unique risk factors for heart disease and a higher risk of cardiovascular mortality. Heart failure (HF) prevalence in women is affected by age, pregnancy, and menopause. More understanding of HF etiology, management, and outcome in women is needed.
Method:
a retrospective study of women diagnosed with HF following at a heart function clinic (HFC) in a tertiary cardiac center.
Results:
A total of 1988 HF patients were screened. Women accounted for 561 (28.2%). The mean age at first HF presentation was 47.7 ± 17.9 years. The most common diagnosis was HF with reduced ejection fraction (HFrEF ≤ 40%) 473 (84%). The most frequent cause of HF was dilated cardiomyopathy (DCM) in 304 patients (54.2%). Prevalence of diabetes (DM) was 272 (48.5%), hypertension (HTN) 267 (47.6%), and body mass index (BMI) ≥ 30 was 332 (59%). Adverse pregnancy events included miscarriages 151 (38.6%), preeclampsia 15 (3.8%), and spontaneous coronary dissection 3 (0.8%). Left ventricle recovery to EF ≥ 50% occurred in 116 (20.7%) patients, while death occurred in 32 (5.7%) patients during follow-up. Women living with chronic HF were 240 (42.8%). The use of beta-blockers occurred in (96%), renin-angiotensin enzyme inhibitors (86.6%), mineralocorticoids (55.4%), and sodium-glucose cotransporter 2 inhibitors (31.6%). Women who had a heart transplant were 19 (3.75%).
Conclusion:
Referral to specialized heart function clinics remains low for women. There is high burden of obesity among women and the majority of women have chronic HF but advanced HF therapy consideration is low in women.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
05:15Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inotropic Agents